Understanding how bacteria resist antibiotics

Antibiotic tolerance: membraneless organelles and autolysin regulation

NIH-funded research St. Jude Children's Research Hospital · NIH-11076643

This study is looking at how a common bacteria, Streptococcus pneumoniae, learns to resist antibiotics and focuses on a specific enzyme called LytA that helps the bacteria break down; the goal is to find new ways to fight antibiotic resistance, which could help patients dealing with tough infections.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionSt. Jude Children's Research Hospital NIH-funded
Lab location1 site (Memphis, United States)
Project IDNIH-11076643 on NIH RePORTER

What this research studies

This research investigates the mechanisms by which the bacteria Streptococcus pneumoniae develop tolerance to antibiotics, particularly focusing on a key enzyme called LytA that is involved in bacterial autolysis. The study aims to identify how LytA is regulated during antibiotic treatment and how this regulation contributes to treatment failure. By exploring the genetic factors that influence LytA activity, the research seeks to uncover new strategies to combat antibiotic resistance. Patients with infections caused by antibiotic-resistant bacteria may benefit from the insights gained through this work.

Who could benefit from this research

Good fit: Ideal candidates for participation or benefit from this research are patients suffering from infections caused by antibiotic-resistant strains of Streptococcus pneumoniae.

Not a fit: Patients with infections caused by bacteria that are not Streptococcus pneumoniae may not receive direct benefits from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that effectively overcome antibiotic tolerance in bacterial infections.

How similar studies have performed: Other research has shown success in understanding antibiotic resistance mechanisms, making this approach promising yet still innovative.

Where this research is happening

Memphis, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.